Rare diseases
Investigational molecules
Locations
Clinical trials in Greece – page 171 088 clinical trials in Greece across 35 research sites in 50 cities. Every trial is listed in the EU Clinical Trials Register and updated daily.
GreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceGreeceWhere most of the country's trials are run
Shares are of these cities' trials together.
50 cities, A–Z – pick yours to filter the trials
What the registry says about research in the country
Greece is actively involved in clinical research focused on oncology and hematological malignancies, with trials addressing a wide range of cancers. Studies encompass non-small cell lung cancer, breast cancer, multiple myeloma, lymphomas, and leukemias. Research efforts concentrate on evaluating novel immunotherapies, targeted therapies, and combination treatment regimens designed to improve patient outcomes and survival rates.
These trials aim to advance precision medicine approaches, optimize treatment sequencing, and identify biomarkers that predict therapeutic response in various cancer types.
Clinical trials in Greece address cardiovascular diseases, including atherosclerotic cardiovascular disease, heart failure, atrial fibrillation, and acute myocardial infarction. Research focuses on novel anticoagulants, anti-inflammatory agents, and therapies targeting specific cardiac pathologies. Studies evaluate interventions to reduce cardiovascular events, improve cardiac function, and manage complications associated with cardiovascular conditions.
These studies seek to establish more effective prevention strategies and therapeutic interventions for patients at high cardiovascular risk.
Research in Greece encompasses a broad spectrum of autoimmune diseases and inflammatory conditions. Trials investigate rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, and multiple sclerosis. Studies evaluate biologic agents, small molecule inhibitors, and immunomodulatory therapies aimed at controlling disease activity, reducing inflammation, and improving quality of life for patients.
The objective is to develop more effective, personalized treatment strategies that achieve disease remission and prevent long-term complications.
Clinical trials in Greece focus on respiratory diseases including chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, and pulmonary arterial hypertension. Research evaluates bronchodilators, anti-inflammatory agents, antifibrotic therapies, and targeted treatments for progressive pulmonary conditions. Studies aim to improve lung function, reduce exacerbations, and slow disease progression.
These studies seek to address unmet medical needs in chronic respiratory diseases and improve patient outcomes through innovative therapeutic approaches.
Greek research sites participate in trials addressing neurological disorders such as Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, and myasthenia gravis. Studies evaluate disease-modifying therapies, symptomatic treatments, and interventions targeting specific pathological mechanisms. Research focuses on slowing cognitive decline, managing neurological symptoms, and improving functional outcomes.
The goal is to develop effective interventions that preserve cognitive function and enhance quality of life for patients with neurodegenerative conditions.
Clinical research in Greece addresses metabolic diseases including type 2 diabetes, obesity, dyslipidemia, and non-alcoholic steatohepatitis. Trials evaluate novel glucose-lowering agents, weight management therapies, lipid-modifying treatments, and interventions for liver disease. Studies aim to improve glycemic control, reduce cardiovascular risk, and manage metabolic complications.
These studies focus on comprehensive metabolic risk management and prevention of long-term complications associated with metabolic disorders.
Research conducted in Greece includes trials on chronic kidney disease, IgA nephropathy, diabetic kidney disease, and related complications. Studies evaluate treatments aimed at slowing disease progression, managing proteinuria, and addressing complications such as anemia and hyperkalemia. Research focuses on novel therapeutic approaches targeting specific disease mechanisms.
The objective is to preserve kidney function, reduce disease progression, and improve outcomes for patients with various forms of kidney disease.
Clinical trials in Greece address dermatological diseases including atopic dermatitis, psoriasis, hidradenitis suppurativa, and chronic spontaneous urticaria. Research evaluates biologic therapies, small molecule inhibitors, and topical treatments designed to control inflammation, reduce symptoms, and improve skin health. Studies aim to achieve disease clearance and enhance patient quality of life.
These studies seek to provide effective long-term management options for patients with chronic inflammatory skin conditions.
Greek research sites participate in trials addressing infectious diseases including bacterial infections, viral infections, and fungal infections. Studies evaluate novel antibiotics, antiviral agents, and antifungal therapies for resistant pathogens and severe infections. Research also includes vaccine studies and prevention strategies for infectious diseases.
The focus is on developing effective treatments for multidrug-resistant infections and improving prevention strategies for vulnerable populations.
Clinical research in Greece encompasses hematological disorders such as hemophilia, paroxysmal nocturnal hemoglobinuria, thalassemia, and immune thrombocytopenia. Trials evaluate gene therapies, novel clotting factors, complement inhibitors, and treatments for inherited blood disorders. Studies aim to reduce bleeding episodes, manage transfusion dependence, and improve quality of life.
These studies focus on transformative therapies that address the underlying causes of blood disorders and reduce treatment burden.
Greece participates in trials addressing rare diseases including Fabry disease, amyloidosis, epidermolysis bullosa, and Duchenne muscular dystrophy. Research evaluates enzyme replacement therapies, gene therapies, and targeted treatments for genetic and metabolic disorders. Studies aim to slow disease progression, manage symptoms, and improve functional outcomes for patients with rare conditions.
The objective is to provide effective treatments for conditions with limited therapeutic options and improve outcomes for rare disease patients.
Clinical trials in Greece address eye diseases including neovascular age-related macular degeneration, glaucoma, diabetic retinopathy, and thyroid eye disease. Studies evaluate anti-VEGF therapies, neuroprotective agents, and treatments for inflammatory and degenerative eye conditions. Research focuses on preserving vision, managing intraocular pressure, and reducing disease-related complications.
These studies aim to develop effective therapies that prevent vision loss and improve quality of life for patients with ocular diseases.
Research in Greece includes trials on gastrointestinal disorders such as inflammatory bowel disease, functional dyspepsia, primary biliary cholangitis, and alcohol-related liver disease. Studies evaluate biologic therapies, small molecule inhibitors, and treatments targeting specific disease mechanisms. Research aims to achieve remission, manage symptoms, and prevent disease complications.
The focus is on improving disease management, achieving mucosal healing, and enhancing quality of life for patients with chronic gastrointestinal conditions.
Greece participates in pediatric clinical trials across various therapeutic areas including oncology, rare diseases, inflammatory conditions, and infectious diseases. Studies evaluate age-appropriate formulations, dosing regimens, and safety profiles of therapies in children and adolescents. Research focuses on conditions such as juvenile idiopathic arthritis, pediatric leukemias, and genetic disorders.
These studies aim to establish safe and effective treatments specifically tailored to the needs of pediatric patients.
Clinical trials in Greece address pain management and musculoskeletal conditions including acute low back pain, osteoarthritis, and rotator cuff tendinopathy. Research evaluates analgesic therapies, anti-inflammatory treatments, and interventions aimed at improving mobility and function. Studies focus on providing effective pain relief while minimizing adverse effects.
The objective is to develop effective pain management strategies that improve patient function and quality of life.
Greece participates in trials involving hematopoietic stem cell transplantation, CAR T-cell therapy, and gene-modified cell therapies. Research evaluates prevention and treatment of complications such as graft-versus-host disease and transplant-associated thrombotic microangiopathy. Studies also include long-term follow-up of patients treated with gene therapies.
These studies aim to improve transplant outcomes and establish the long-term safety and efficacy of advanced cellular therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
